Review Performance of New Active Substances in Taiwan: A 10-Year Retrospective Analysis (2015-2024).

Huang CY, Chen LK, Hsu BK, Cheng HF, Wu CH

Open source

DOI
10.1007/s43441-026-01038-3
Published
2026 Sep 1
Container
Therapeutic innovation & regulatory science
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s43441-026-01038-3,
  title = {Review Performance of New Active Substances in Taiwan: A 10-Year Retrospective Analysis (2015-2024).},
  author = {Huang CY and Chen LK and Hsu BK and Cheng HF and Wu CH},
  year = {2026},
  journal = {Therapeutic innovation \& regulatory science},
  doi = {10.1007/s43441-026-01038-3},
  url = {https://doi.org/10.1007/s43441-026-01038-3}
}

RIS

TY  - JOUR
TI  - Review Performance of New Active Substances in Taiwan: A 10-Year Retrospective Analysis (2015-2024).
AU  - Huang CY
AU  - Chen LK
AU  - Hsu BK
AU  - Cheng HF
AU  - Wu CH
PY  - 2026
JO  - Therapeutic innovation & regulatory science
DO  - 10.1007/s43441-026-01038-3
UR  - https://doi.org/10.1007/s43441-026-01038-3
ER  - 

APA

CY, H., LK, C., BK, H., HF, C., & CH, W. (2026). Review Performance of New Active Substances in Taiwan: A 10-Year Retrospective Analysis (2015-2024).. Therapeutic innovation & regulatory science. https://doi.org/10.1007/s43441-026-01038-3

Source records